We are live on
!
Find out more
GCM
Galibier Capital Management Portfolio holdings
AUM
$300M
1-Year Est. Return
22.03%
This Fund
S&P 500
This Quarter
Est. Return
+1.95%
1 Year Est. Return
+22.03%
3 Year Est. Return
+66.83%
5 Year Est. Return
+107.72%
10 Year Est. Return
–
AUM
$220M
AUM Growth
+$52.1M
(+31%)
Cap. Flow
+$47.9M
Cap. Flow
% of AUM
21.82%
Top 10 Holdings %
Top 10 Hldgs %
77.75%
Holding
34
New
3
Increased
17
Reduced
5
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nutrien
NTR
|
+$23.7M |
| 2 |
Emerson Electric
EMR
|
+$12.3M |
| 3 |
Medtronic
MDT
|
+$10.4M |
| 4 |
Enbridge
ENB
|
+$3.59M |
| 5 |
Manulife Financial
MFC
|
+$3.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$6.89M |
| 2 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$1.75M |
| 3 |
Merck
MRK
|
+$1.4M |
| 4 |
Oshkosh
OSK
|
+$833K |
| 5 |
Middleby
MIDD
|
+$672K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 33.21% |
| 2 | Energy | 16.07% |
| 3 | Industrials | 14.58% |
| 4 | Healthcare | 14.28% |
| 5 | Materials | 11.09% |
Similar funds
LIG
LSA
OPPS
FIBT
SFG
FW
SC
AFWM
Galibier Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Galibier Capital Management held 34 positions worth $220M, up 31% from $168M the previous quarter. Its ten largest holdings account for 78% of the portfolio.
Galibier Capital Management deployed $47.9M of net new capital in Q2 2019, opening 3 new positions and adding to 17 existing holdings. Its largest new stake was Nutrien: 454,391 shares worth $24.4M.
By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 40% a quarter earlier, followed by Energy and Industrials.
On the sell side, the largest reduction was Oshkosh, an estimated $833K trimmed.
- Galibier Capital Management's largest Q2 2019 buy was Nutrien: 454,391 shares worth $24.4M.
- Galibier Capital Management added most to Emerson Electric in Q2 2019, an estimated $12.3M increase.
- Galibier Capital Management's biggest Q2 2019 reduction was Oshkosh, cutting an estimated $833K.
- Galibier Capital Management fully exited Biogen in Q2 2019, selling an estimated $6.89M.
- Galibier Capital Management's ten largest holdings make up 78% of its $220M portfolio in Q2 2019.
- Galibier Capital Management opened 3 new positions and closed 3 in Q2 2019.
- Galibier Capital Management's portfolio value rose 31% quarter-over-quarter to $220M.
Based on Galibier Capital Management's 13F filing for Q2 2019, filed 2 Aug 2019.